SIREN : 907711196
BIONORMANDE is a French company founded 4 years ago, specialized in the sector Commerce d'alimentation générale. Based in NEUFCHATEL-EN-BRAY (76270), this company of category PME shows in 2024 a net income positive of 44 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 |
|---|---|---|
| Revenue | N/C | N/C |
| Net income | 44 051 € | 71 757 € |
| EBITDA | N/C | N/C |
| Net margin | N/C | N/C |
In 2024, BIONORMANDE generates positive net income of 44 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2023-2024: 72 k€ -> 44 k€.
44 051 €
The debt ratio (= Financial debt / Equity x 100) stands at 502%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 15%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
502.422%
14.531%
65.1%
In 2024, the debt ratio of BIONORMANDE (502.42) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
In 2024, the financial autonomy of BIONORMANDE (14.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
The liquidity ratio (= Current assets / Current liabilities) stands at 445.57. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
445.573
In 2024, the liquidity ratio of BIONORMANDE (445.57) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Based on 551 transactions of similar company sales in 2024, the value of BIONORMANDE is estimated at 256 627 € (range 115 767€ - 579 543€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 551 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare BIONORMANDE with other companies in the same sector:
Voir toutes les statistiques du secteur Commerce d'alimentation générale
The revenue of BIONORMANDE is not publicly disclosed (confidential accounts filed with INPI).
Yes, BIONORMANDE generated a net profit of 44 k€ in 2024.
The headquarters of BIONORMANDE is located in NEUFCHATEL-EN-BRAY (76270), in the department Seine-Maritime.
The tax return of BIONORMANDE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BIONORMANDE operates in the sector Commerce d'alimentation générale (NAF code 47.11B). See the 'Sector positioning' section above to compare the company with its competitors.